Surgery Partners (SGRY) | Financial Analysis & Statements
Surgery Partners Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
885.0M
Gross Profit
212.2M
23.98%
Operating Income
124.8M
14.10%
Net Income
29.0M
3.28%
EPS (Diluted)
$-0.12
Balance Sheet Metrics
Total Assets
8.1B
Total Liabilities
4.6B
Shareholders Equity
3.5B
Debt to Equity
1.30
Cash Flow Metrics
Operating Cash Flow
93.8M
Free Cash Flow
90.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Surgery Partners Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.3B | 3.1B | 2.7B | 2.5B | 2.2B |
| Cost of Goods Sold | 2.5B | 2.4B | 2.1B | 2.0B | 1.7B |
| Gross Profit | 765.0M | 745.6M | 647.5M | 574.9M | 491.4M |
| Gross Margin % | 23.1% | 23.9% | 23.6% | 22.6% | 22.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 118.2M | 138.7M | 120.9M | 102.2M | 104.0M |
| Other Operating Expenses | - | - | -1.1M | -2.4M | -37.9M |
| Total Operating Expenses | 118.2M | 138.7M | 119.8M | 99.8M | 66.1M |
| Operating Income | 470.8M | 454.3M | 409.6M | 360.3M | 326.5M |
| Operating Margin % | 14.2% | 14.6% | 14.9% | 14.2% | 14.7% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 272.6M | 201.7M | 193.0M | 234.9M | 221.0M |
| Other Non-Operating Income | -81.3M | -105.5M | -81.6M | -15.1M | -24.3M |
| Pre-tax Income | 116.9M | 147.1M | 135.0M | 110.3M | 81.2M |
| Income Tax | 18.0M | 134.6M | 300.0K | 23.3M | 10.5M |
| Effective Tax Rate % | 15.4% | 91.5% | 0.2% | 21.1% | 12.9% |
| Net Income | 98.9M | 12.5M | 135.3M | 87.0M | 70.7M |
| Net Margin % | 3.0% | 0.4% | 4.9% | 3.4% | 3.2% |
| Key Metrics | |||||
| EBITDA | 678.4M | 646.4M | 548.3M | 504.2M | 452.1M |
| EPS (Basic) | $-0.61 | $-1.33 | $-0.09 | $-0.59 | $-1.12 |
| EPS (Diluted) | $-0.61 | $-1.33 | $-0.09 | $-0.59 | $-1.12 |
| Basic Shares Outstanding | 127209000 | 126122000 | 125613000 | 91952000 | 72427000 |
| Diluted Shares Outstanding | 127209000 | 126122000 | 125613000 | 91952000 | 72427000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Surgery Partners Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 239.9M | 269.5M | 195.9M | 282.9M | 389.9M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 602.2M | 579.1M | 496.4M | 456.3M | 430.2M |
| Inventory | 96.6M | 88.4M | 75.2M | 71.4M | 61.1M |
| Other Current Assets | 212.0M | 182.4M | 127.5M | 110.4M | 64.9M |
| Total Current Assets | 1.2B | 1.1B | 895.0M | 921.0M | 946.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.6B | 1.5B | 1.3B | 1.2B | 938.7M |
| Goodwill | 10.4B | 10.2B | 8.7B | 8.3B | 7.9B |
| Intangible Assets | 41.0M | 45.7M | 54.8M | 42.3M | 43.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 56.8M | 57.5M | 192.8M | 235.7M | 173.5M |
| Total Non-Current Assets | 7.0B | 6.8B | 6.0B | 5.8B | 5.2B |
| Total Assets | 8.1B | 7.9B | 6.9B | 6.7B | 6.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 208.7M | 208.7M | 171.8M | 151.6M | 124.9M |
| Short-term Debt | 142.0M | 142.4M | 110.9M | 99.3M | 100.5M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 4.7M | 24.8M | 34.1M | 52.3M | 47.3M |
| Total Current Liabilities | 615.5M | 624.4M | 523.0M | 493.4M | 536.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.9B | 3.6B | 3.0B | 2.8B | 3.2B |
| Deferred Tax Liabilities | 53.4M | 39.2M | - | - | - |
| Other Non-Current Liabilities | 41.2M | 30.2M | 41.1M | 75.4M | 87.0M |
| Total Non-Current Liabilities | 4.0B | 3.6B | 3.0B | 2.9B | 3.3B |
| Total Liabilities | 4.6B | 4.3B | 3.5B | 3.4B | 3.8B |
| Equity | |||||
| Common Stock | 1.3M | 1.3M | 1.3M | 1.3M | 900.0K |
| Retained Earnings | -815.2M | -737.3M | -569.2M | -557.3M | -502.7M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.5B | 3.6B | 3.4B | 3.3B | 2.3B |
| Key Metrics | |||||
| Total Debt | 4.0B | 3.7B | 3.1B | 2.9B | 3.3B |
| Working Capital | 535.2M | 495.0M | 372.0M | 427.6M | 409.3M |
Balance Sheet Composition
Surgery Partners Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 98.9M | 12.5M | 135.3M | 87.0M | 70.7M |
| Depreciation & Amortization | 176.0M | 152.6M | 118.1M | 114.8M | 98.8M |
| Stock-Based Compensation | 14.8M | 33.3M | 17.7M | 18.4M | 17.4M |
| Working Capital Changes | -110.4M | -118.9M | -62.3M | -102.3M | -75.5M |
| Operating Cash Flow | 243.4M | 256.4M | 266.1M | 134.6M | 75.6M |
| Investing Activities | |||||
| Capital Expenditures | -32.2M | -87.8M | -63.0M | -67.7M | -51.6M |
| Acquisitions | -173.9M | -375.9M | -128.9M | -228.7M | -280.4M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -246.6M | -488.5M | -225.6M | -307.9M | -331.7M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | 0 | 0 | -5.1M |
| Debt Issuance | 1.2B | 1.7B | 826.6M | 217.8M | 299.4M |
| Debt Repayment | -1.0B | -1.3B | -807.1M | -862.0M | -343.2M |
| Financing Cash Flow | -57.3M | 262.0M | -155.2M | 42.1M | 316.3M |
| Free Cash Flow | 195.6M | 209.7M | 205.0M | 78.2M | 29.5M |
| Net Change in Cash | -60.5M | 29.9M | -114.7M | -131.2M | 60.2M |
Cash Flow Trend
Surgery Partners Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
2,956.00
Forward P/E
37.68
Price to Book
1.09
Price to Sales
0.57
PEG Ratio
-34.35
Profitability Ratios
Profit Margin
-2.35%
Operating Margin
15.09%
Return on Equity
2.76%
Return on Assets
3.74%
Financial Health
Current Ratio
1.87
Debt to Equity
114.51
Beta
1.99
Per Share Data
EPS (TTM)
$-0.61
Book Value per Share
$13.37
Revenue per Share
$26.01
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SGRY | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
| Addus HomeCare | 1.8B | 18.10 | 1.58 | 9.33% | 6.74% | 15.79 |
Financial data is updated regularly. All figures are in the company's reporting currency.






